Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -8.516% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. O=C(CSc1nnc(-c2ccc(F)cc2)c2ccccc12)Nc1ccccc1Cl
b. Cc1nn(-c2ccccc2)c(NC(=O)c2cccs2)c(-c2ccccc2Cl)c1=O
c. O=C(O)CCc1nn2c3ccccc3nc2n(Cc2ccccc2)c1=O
Answer: a. O=C(CSc1nnc(-c2ccc(F)cc2)c2ccccc12)Nc1ccccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nnc(-c2ccc(F)cc2)c2ccccc12)Nc1ccccc1Cl
O=C(CSc1nnc(-c2ccc(F)cc2)c2ccccc12)Nc1ccccc1Cl
N-(2-chlorophenyl)-2-[1-(4-fluorophenyl)benzo[d]pyridazin-4-yl]sulfanylacetamide